Richard Hague

Richard Hague

Chief Executive Officer at REGENETP, INC.

Net worth: 4 445 $ as of 30/03/2024

63 year
Health Technology
Consumer Services

Profile

Richard Hague is currently the President, Chief Executive Officer & Director at RegenETP, Inc. He is also the Chief Executive Officer at PolarityTE MD, Inc. Previously, he held positions as the Senior Director at Genzyme Biosurgery Corp.
from 2001 to 2005, the Chief Commercial Officer at Anika Therapeutics, Inc. from 2015 to 2019, the Vice President-Sales & Marketing at TEI Medical, Inc. from 2004 to 2015, and the VP-Sales, Marketing & Commercial Operations at Sanofi UK from 2011 to 2014.
Mr. Hague obtained his undergraduate degree from the University of Connecticut.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/03/2023 44,453 ( 0.60% ) 4 445 $ 30/03/2024

Richard Hague active positions

CompaniesPositionStart
REGENETP, INC. Chief Executive Officer 31/08/2021
Chief Executive Officer -
All active positions of Richard Hague

Former positions of Richard Hague

CompaniesPositionEnd
ANIKA THERAPEUTICS, INC. Corporate Officer/Principal 04/04/2019
Sales & Marketing 30/09/2015
Sales & Marketing 31/12/2013
Director/Board Member 31/12/2004
See the detail of Richard Hague's experience

Training of Richard Hague

University of Connecticut Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Hague's experience

Connections

46

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ANIKA THERAPEUTICS, INC.

Health Technology

REGENETP, INC.

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Health Technology

See company connections